SP
EW icon

Sarasin & Partners’s Edwards Lifesciences EW Stock Holding History

Sarasin & Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-219,490
Closed -$20.3M – 83
2024
Q2 		$20.3M Buy
219,490
+3,104
+1% +$275K 0.18% 42
2024
Q1 		$20.7M Sell
216,386
-15,830
-7% -$1.33M 0.2% 43
2023
Q4 		$17.7M Sell
232,216
-39,987
-15% -$2.78M 0.19% 48
2023
Q3 		$18.9M Buy
272,203
+3,525
+1% +$283K 0.24% 45
2023
Q2 		$25.3M Buy
268,678
+12,950
+5% +$1.13M 0.29% 43
2023
Q1 		$21.2M Sell
255,728
-145
-0.1% -$11.4K 0.27% 48
2022
Q4 		$19.1M Buy
255,873
+2,799
+1% +$216K 0.25% 53
2022
Q3 		$20.9M Sell
253,074
-456
-0.2% -$43.9K 0.29% 51
2022
Q2 		$24.1M Buy
+253,530
New +$26.2M 0.3% 54
2022
Q1 		– Sell
-254,535
Closed -$33M – 91
2021
Q4 		$33M Hold
254,535
– – 0.3% 57
2021
Q3 		$28.8M Hold
254,535
– – 0.29% 58
2021
Q2 		$26.4M Buy
254,535
+52,386
+26% +$4.94M 0.28% 55
2021
Q1 		$16.9M Hold
202,149
– – 0.2% 60
2020
Q4 		$18.4M Buy
202,149
+38,676
+24% +$3.21M 0.24% 57
2020
Q3 		$13M Buy
163,473
+31,473
+24% +$2.46M 0.19% 62
2020
Q2 		$9.12M Buy
+132,000
New +$9.38M 0.15% 67
2020
Q1 		– Sell
-95,769
Closed -$7.45M – 112
2019
Q4 		$7.45M Sell
95,769
-261
-0.3% -$20.4K 0.11% 83
2019
Q3 		$7.04M Buy
96,030
+30,405
+46% +$2.14M 0.12% 82
2019
Q2 		$4.04M Sell
65,625
-765
-1% -$46.3K 0.07% 99
2019
Q1 		$4.23M Hold
66,390
– – 0.08% 89
2018
Q4 		$3.39M Hold
66,390
– – 0.07% 91
2018
Q3 		$3.85M Buy
+66,390
New +$3.25M 0.07% 95

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Sarasin & Partners's EW Position: Q3 2024 in Review

Sarasin & Partners sold out of Edwards Lifesciences (EW) in Q3 2024, closing a stake of 219,490 shares — an estimated $20.3M sold.

Sarasin & Partners first reported a position in EW in Q3 2018 and held it in 22 quarters. The position peaked at $33M in Q4 2021. 1,194 funds tracked by Wall St. Rank hold EW as of Q3 2024.

  • Sarasin & Partners reported no remaining Edwards Lifesciences position as of Q3 2024 after selling out during the quarter.
  • Sarasin & Partners sold 219,490 Edwards Lifesciences shares in Q3 2024, an estimated $20.3M.
  • Sarasin & Partners first reported a position in Edwards Lifesciences in Q3 2018 and held it in 22 quarters.
  • Sarasin & Partners's Edwards Lifesciences position peaked at $33M in Q4 2021.
  • 1,194 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2024.

Based on Sarasin & Partners's 13F filing for Q3 2024, filed 9 Oct 2024.